Andrews Julie 4

What Happened

• Julie Andrews, Chief Financial Officer of Orthofix Medical Inc. (OFIX), sold 4,873 shares of common stock on January 16, 2026 at $14.38 per share, generating proceeds of approximately $70,074. The filing reports this as a sale to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Key Details

• Transaction date and price: 2026-01-16 — 4,873 shares sold at $14.38 each.
• Total proceeds: ~$70,074.
• Shares owned after transaction: the filing references 45,590 previously reported restricted stock units (RSUs); the filing does not state a consolidated total share count after the sale.
• Footnotes: F1 — sale was a pre-existing "sell-to-cover" to satisfy tax withholding for RSU settlement and was executed without the reporting person’s discretion. F2 — includes 45,590 previously reported RSUs.
• Filing timing: Form 4 was filed on 2026-01-21 reporting the 2026-01-16 transaction (filed five days after the transaction).

Context

• This was a routine sell-to-cover to meet tax obligations tied to RSU vesting, not an open-market discretionary sale intended to signal a change in view. Such withholding sales are common and generally not interpreted as a direct indicator of insider sentiment.